Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
13 Results for "
JMJD2C
" in MedChemExpress (MCE) Product Catalog:
Products (13)
13 Results for "JMJD2C" in MCE Product Catalog:
21
21 Cited Publications
Target:
Research Areas:
JIB-04 is a pan-selective Jumonji histone demethylase inihibitor with IC50s of 230, 340, 855, 445, 435, 1100, and 290 nM for JARID1A, JMJD2E, JMJD3, JMJD2A, JMJD2B, JMJD2C, and JMJD2D, respectively.
1
Research Areas:
N-Oxalylglycine (N-Oxaloglycine) is a Jumonji C-domain-containing histone lysine demethylase inhibitor. N-Oxalylglycine inhibits JMJD2A, JMJD2C and JMJD2D. N-Oxalylglycine also inhibits HIF prolylhydroxylase domain-1 (PHD-1) and PHD-2, with an IC50 of 2.1 μM and 5.6 μM, respectively [2].
Target:
Research Areas:
SD-70 is an inhibitor for histone demethylase JMJD2C and exhibits antitumor efficacy. SD-70 inhibits viability of cancer cells CWR22Rv1 (9% cell survival at 10 μM), PC3 (14% cell survival at 2 μM) and DU145 (26% cell survival at 2 μM) .
Target:
Research Areas:
JHDM-IN-1 (Compound 1) is a Jumonji C domain-containing HDMs (JHDM) inhibitor with IC50s of 3.4, 4.3, 5.9, 10 and 43 μM against JMJD2C, JMJD2A, JMJD2E, PHF8 and JMJD3, respectively .
Cat. No.: HY-RS07215
Target:
Research Areas:
KDM4C Human Pre-designed siRNA Set A contains three designed siRNAs for KDM4C gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
Research Areas:
N-Oxalylglycine (Standard) is the analytical standard of N-Oxalylglycine. This product is intended for research and analytical applications. N-Oxalylglycine (N-Oxaloglycine) is a Jumonji C-domain-containing histone lysine demethylase inhibitor. N-Oxalylglycine inhibits JMJD2A, JMJD2C and JMJD2D. N-Oxalylglycine also inhibits HIF prolylhydroxylase domain-1 (PHD-1) and PHD-2, with an IC50 of 2.1 μM and 5.6 μM, respectively [2].
Cat. No.: HY-116796
CAS No.: 23705-85-3
Target:
Research Areas:
KDM4C-IN-2 is a histone lysine demethylase KDM4C (JMJD2C) inhibitor with an IC50 of 147 μM and a Ki of 51 μM. KDM4C-IN-2 can be used for the research of cancer, such as prostate and breast cancer .
Cat. No.: HY-P703619
Purity: ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: GASC1; JHDM3C; JMJD2C; KIAA0780
Cat. No.: HY-P702951
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: GASC1; JHDM3C; JMJD2C; KIAA0780
Species:
Source:
Cat. No.: HY-RS24301
Target:
Research Areas:
Kdm4c Rat Pre-designed siRNA Set A contains three designed siRNAs for Kdm4c gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-RS17833
Target:
Research Areas:
Kdm4c Mouse Pre-designed siRNA Set A contains three designed siRNAs for Kdm4c gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.
- 1
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
